nodes	percent_of_prediction	percent_of_DWPC	metapath
Celecoxib—PTGS2—ovarian follicle—polycystic ovary syndrome	0.018	0.0661	CbGeAlD
Celecoxib—Angina unstable—Metformin—polycystic ovary syndrome	0.0166	0.111	CcSEcCtD
Celecoxib—PDPK1—embryo—polycystic ovary syndrome	0.0158	0.0582	CbGeAlD
Celecoxib—PDPK1—uterus—polycystic ovary syndrome	0.0107	0.0392	CbGeAlD
Celecoxib—PDPK1—pituitary gland—polycystic ovary syndrome	0.0105	0.0385	CbGeAlD
Celecoxib—PDPK1—adipose tissue—polycystic ovary syndrome	0.0104	0.0384	CbGeAlD
Celecoxib—PDPK1—adrenal gland—polycystic ovary syndrome	0.00935	0.0344	CbGeAlD
Celecoxib—PDPK1—female gonad—polycystic ovary syndrome	0.00872	0.0321	CbGeAlD
Celecoxib—PDPK1—vagina—polycystic ovary syndrome	0.00866	0.0319	CbGeAlD
Celecoxib—CYP2C9—urine—polycystic ovary syndrome	0.00862	0.0317	CbGeAlD
Celecoxib—MAPK14—embryo—polycystic ovary syndrome	0.00845	0.0311	CbGeAlD
Celecoxib—PDPK1—endocrine gland—polycystic ovary syndrome	0.00811	0.0298	CbGeAlD
Celecoxib—CA5A—endocrine gland—polycystic ovary syndrome	0.00761	0.028	CbGeAlD
Celecoxib—CYP3A4—urine—polycystic ovary syndrome	0.00657	0.0242	CbGeAlD
Celecoxib—Nail disorder—Metformin—polycystic ovary syndrome	0.00648	0.0431	CcSEcCtD
Celecoxib—CYP2D6—urine—polycystic ovary syndrome	0.00647	0.0238	CbGeAlD
Celecoxib—MAPK14—uterus—polycystic ovary syndrome	0.0057	0.021	CbGeAlD
Celecoxib—MAPK14—pituitary gland—polycystic ovary syndrome	0.0056	0.0206	CbGeAlD
Celecoxib—MAPK14—adipose tissue—polycystic ovary syndrome	0.00557	0.0205	CbGeAlD
Celecoxib—Fungal infection—Metformin—polycystic ovary syndrome	0.00544	0.0362	CcSEcCtD
Celecoxib—MAPK14—adrenal gland—polycystic ovary syndrome	0.005	0.0184	CbGeAlD
Celecoxib—CA14—adrenal gland—polycystic ovary syndrome	0.00486	0.0179	CbGeAlD
Celecoxib—MAPK14—female gonad—polycystic ovary syndrome	0.00466	0.0172	CbGeAlD
Celecoxib—MAPK14—vagina—polycystic ovary syndrome	0.00463	0.0171	CbGeAlD
Celecoxib—CA9—endocrine gland—polycystic ovary syndrome	0.00445	0.0164	CbGeAlD
Celecoxib—MAPK14—endocrine gland—polycystic ovary syndrome	0.00434	0.016	CbGeAlD
Celecoxib—Neuropathy—Metformin—polycystic ovary syndrome	0.00395	0.0262	CcSEcCtD
Celecoxib—CA5B—adipose tissue—polycystic ovary syndrome	0.00379	0.014	CbGeAlD
Celecoxib—ORM1—endometrium—polycystic ovary syndrome	0.00372	0.0137	CbGeAlD
Celecoxib—Ear pain—Metformin—polycystic ovary syndrome	0.00358	0.0238	CcSEcCtD
Celecoxib—CA5B—adrenal gland—polycystic ovary syndrome	0.0034	0.0125	CbGeAlD
Celecoxib—CA2—embryo—polycystic ovary syndrome	0.00329	0.0121	CbGeAlD
Celecoxib—CA12—endocrine gland—polycystic ovary syndrome	0.00329	0.0121	CbGeAlD
Celecoxib—CA5B—vagina—polycystic ovary syndrome	0.00315	0.0116	CbGeAlD
Celecoxib—Hypoglycaemia—Metformin—polycystic ovary syndrome	0.00313	0.0208	CcSEcCtD
Celecoxib—Migraine—Metformin—polycystic ovary syndrome	0.003	0.02	CcSEcCtD
Celecoxib—CA5B—endocrine gland—polycystic ovary syndrome	0.00295	0.0109	CbGeAlD
Celecoxib—ABCC4—uterus—polycystic ovary syndrome	0.00291	0.0107	CbGeAlD
Celecoxib—ABCC4—adipose tissue—polycystic ovary syndrome	0.00285	0.0105	CbGeAlD
Celecoxib—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.00282	0.0187	CcSEcCtD
Celecoxib—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.00279	0.0185	CcSEcCtD
Celecoxib—Breast disorder—Metformin—polycystic ovary syndrome	0.00276	0.0183	CcSEcCtD
Celecoxib—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.00273	0.0181	CcSEcCtD
Celecoxib—CA2—adrenal cortex—polycystic ovary syndrome	0.0027	0.00993	CbGeAlD
Celecoxib—ALB—adrenal gland—polycystic ovary syndrome	0.00264	0.00971	CbGeAlD
Celecoxib—CA4—pituitary gland—polycystic ovary syndrome	0.00263	0.00968	CbGeAlD
Celecoxib—CA4—adipose tissue—polycystic ovary syndrome	0.00262	0.00964	CbGeAlD
Celecoxib—ORM1—endocrine gland—polycystic ovary syndrome	0.00261	0.00961	CbGeAlD
Celecoxib—Pancreatitis—Metformin—polycystic ovary syndrome	0.00259	0.0172	CcSEcCtD
Celecoxib—Sweating increased—Metformin—polycystic ovary syndrome	0.00257	0.0171	CcSEcCtD
Celecoxib—Angina pectoris—Metformin—polycystic ovary syndrome	0.00257	0.0171	CcSEcCtD
Celecoxib—ABCC4—adrenal gland—polycystic ovary syndrome	0.00255	0.0094	CbGeAlD
Celecoxib—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.00245	0.0163	CcSEcCtD
Celecoxib—PTGS2—embryo—polycystic ovary syndrome	0.00243	0.00894	CbGeAlD
Celecoxib—ABCC4—female gonad—polycystic ovary syndrome	0.00238	0.00877	CbGeAlD
Celecoxib—Infestation NOS—Metformin—polycystic ovary syndrome	0.00235	0.0156	CcSEcCtD
Celecoxib—Infestation—Metformin—polycystic ovary syndrome	0.00235	0.0156	CcSEcCtD
Celecoxib—CA4—adrenal gland—polycystic ovary syndrome	0.00235	0.00864	CbGeAlD
Celecoxib—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.00231	0.0153	CcSEcCtD
Celecoxib—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.00222	0.0148	CcSEcCtD
Celecoxib—ABCC4—endocrine gland—polycystic ovary syndrome	0.00222	0.00815	CbGeAlD
Celecoxib—CA4—female gonad—polycystic ovary syndrome	0.00219	0.00806	CbGeAlD
Celecoxib—CA2—pituitary gland—polycystic ovary syndrome	0.00218	0.00802	CbGeAlD
Celecoxib—CA2—adipose tissue—polycystic ovary syndrome	0.00217	0.00799	CbGeAlD
Celecoxib—Rhinitis—Metformin—polycystic ovary syndrome	0.00212	0.0141	CcSEcCtD
Celecoxib—Hepatitis—Metformin—polycystic ovary syndrome	0.00211	0.014	CcSEcCtD
Celecoxib—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.0021	0.014	CcSEcCtD
Celecoxib—Oedema peripheral—Metformin—polycystic ovary syndrome	0.00208	0.0138	CcSEcCtD
Celecoxib—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.00207	0.0138	CcSEcCtD
Celecoxib—CA4—endocrine gland—polycystic ovary syndrome	0.00204	0.0075	CbGeAlD
Celecoxib—PTGS2—adrenal cortex—polycystic ovary syndrome	0.00199	0.00733	CbGeAlD
Celecoxib—Eye disorder—Metformin—polycystic ovary syndrome	0.00197	0.0131	CcSEcCtD
Celecoxib—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00196	0.013	CcSEcCtD
Celecoxib—Flushing—Metformin—polycystic ovary syndrome	0.00196	0.013	CcSEcCtD
Celecoxib—CA2—adrenal gland—polycystic ovary syndrome	0.00195	0.00717	CbGeAlD
Celecoxib—Angiopathy—Metformin—polycystic ovary syndrome	0.00192	0.0127	CcSEcCtD
Celecoxib—Immune system disorder—Metformin—polycystic ovary syndrome	0.00191	0.0127	CcSEcCtD
Celecoxib—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.0019	0.0127	CcSEcCtD
Celecoxib—CA2—female gonad—polycystic ovary syndrome	0.00182	0.00668	CbGeAlD
Celecoxib—Flatulence—Metformin—polycystic ovary syndrome	0.00181	0.012	CcSEcCtD
Celecoxib—CA2—vagina—polycystic ovary syndrome	0.0018	0.00664	CbGeAlD
Celecoxib—Dysgeusia—Metformin—polycystic ovary syndrome	0.0018	0.012	CcSEcCtD
Celecoxib—PTGS2—endometrium—polycystic ovary syndrome	0.00178	0.00655	CbGeAlD
Celecoxib—Muscle spasms—Metformin—polycystic ovary syndrome	0.00177	0.0117	CcSEcCtD
Celecoxib—Vision blurred—Metformin—polycystic ovary syndrome	0.00173	0.0115	CcSEcCtD
Celecoxib—CA2—endocrine gland—polycystic ovary syndrome	0.00169	0.00621	CbGeAlD
Celecoxib—Syncope—Metformin—polycystic ovary syndrome	0.00165	0.011	CcSEcCtD
Celecoxib—PTGS2—uterus—polycystic ovary syndrome	0.00164	0.00603	CbGeAlD
Celecoxib—Palpitations—Metformin—polycystic ovary syndrome	0.00162	0.0108	CcSEcCtD
Celecoxib—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00162	0.0107	CcSEcCtD
Celecoxib—PTGS2—pituitary gland—polycystic ovary syndrome	0.00161	0.00592	CbGeAlD
Celecoxib—PTGS2—adipose tissue—polycystic ovary syndrome	0.0016	0.0059	CbGeAlD
Celecoxib—Hypertension—Metformin—polycystic ovary syndrome	0.00159	0.0106	CcSEcCtD
Celecoxib—Chest pain—Metformin—polycystic ovary syndrome	0.00156	0.0104	CcSEcCtD
Celecoxib—Myalgia—Metformin—polycystic ovary syndrome	0.00156	0.0104	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00155	0.0103	CcSEcCtD
Celecoxib—Oedema—Metformin—polycystic ovary syndrome	0.0015	0.00997	CcSEcCtD
Celecoxib—Infection—Metformin—polycystic ovary syndrome	0.00149	0.00991	CcSEcCtD
Celecoxib—Shock—Metformin—polycystic ovary syndrome	0.00148	0.00981	CcSEcCtD
Celecoxib—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00147	0.00978	CcSEcCtD
Celecoxib—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00147	0.00977	CcSEcCtD
Celecoxib—Skin disorder—Metformin—polycystic ovary syndrome	0.00146	0.00969	CcSEcCtD
Celecoxib—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00145	0.00964	CcSEcCtD
Celecoxib—PTGS2—adrenal gland—polycystic ovary syndrome	0.00144	0.00529	CbGeAlD
Celecoxib—Anorexia—Metformin—polycystic ovary syndrome	0.00143	0.00951	CcSEcCtD
Celecoxib—CYP2C9—endocrine gland—polycystic ovary syndrome	0.00143	0.00526	CbGeAlD
Celecoxib—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00137	0.00909	CcSEcCtD
Celecoxib—Paraesthesia—Metformin—polycystic ovary syndrome	0.00135	0.00896	CcSEcCtD
Celecoxib—PTGS2—female gonad—polycystic ovary syndrome	0.00134	0.00493	CbGeAlD
Celecoxib—Dyspnoea—Metformin—polycystic ovary syndrome	0.00134	0.00889	CcSEcCtD
Celecoxib—Somnolence—Metformin—polycystic ovary syndrome	0.00133	0.00887	CcSEcCtD
Celecoxib—PTGS2—vagina—polycystic ovary syndrome	0.00133	0.0049	CbGeAlD
Celecoxib—Dyspepsia—Metformin—polycystic ovary syndrome	0.00132	0.00878	CcSEcCtD
Celecoxib—Decreased appetite—Metformin—polycystic ovary syndrome	0.0013	0.00867	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00129	0.00861	CcSEcCtD
Celecoxib—Fatigue—Metformin—polycystic ovary syndrome	0.00129	0.0086	CcSEcCtD
Celecoxib—Constipation—Metformin—polycystic ovary syndrome	0.00128	0.00853	CcSEcCtD
Celecoxib—PTGS2—endocrine gland—polycystic ovary syndrome	0.00125	0.00459	CbGeAlD
Celecoxib—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00124	0.00822	CcSEcCtD
Celecoxib—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00123	0.00816	CcSEcCtD
Celecoxib—Urticaria—Metformin—polycystic ovary syndrome	0.00119	0.00792	CcSEcCtD
Celecoxib—Abdominal pain—Metformin—polycystic ovary syndrome	0.00119	0.00788	CcSEcCtD
Celecoxib—CYP2D6—female gonad—polycystic ovary syndrome	0.00115	0.00424	CbGeAlD
Celecoxib—CYP3A4—endocrine gland—polycystic ovary syndrome	0.00109	0.00401	CbGeAlD
Celecoxib—Asthenia—Metformin—polycystic ovary syndrome	0.00108	0.00716	CcSEcCtD
Celecoxib—CYP2D6—endocrine gland—polycystic ovary syndrome	0.00107	0.00395	CbGeAlD
Celecoxib—Pruritus—Metformin—polycystic ovary syndrome	0.00106	0.00706	CcSEcCtD
Celecoxib—Diarrhoea—Metformin—polycystic ovary syndrome	0.00103	0.00682	CcSEcCtD
Celecoxib—Dizziness—Metformin—polycystic ovary syndrome	0.000992	0.0066	CcSEcCtD
Celecoxib—Vomiting—Metformin—polycystic ovary syndrome	0.000954	0.00634	CcSEcCtD
Celecoxib—Rash—Metformin—polycystic ovary syndrome	0.000946	0.00629	CcSEcCtD
Celecoxib—Dermatitis—Metformin—polycystic ovary syndrome	0.000945	0.00628	CcSEcCtD
Celecoxib—Headache—Metformin—polycystic ovary syndrome	0.00094	0.00625	CcSEcCtD
Celecoxib—Nausea—Metformin—polycystic ovary syndrome	0.000891	0.00592	CcSEcCtD
Celecoxib—ALB—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	5.53e-05	9.58e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—RBP4—polycystic ovary syndrome	5.53e-05	9.58e-05	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—AKT2—polycystic ovary syndrome	5.53e-05	9.57e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—TEAD2—polycystic ovary syndrome	5.52e-05	9.55e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—AKR1C2—polycystic ovary syndrome	5.52e-05	9.55e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—AKR1C1—polycystic ovary syndrome	5.49e-05	9.49e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—AKR1C2—polycystic ovary syndrome	5.47e-05	9.46e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—TEAD2—polycystic ovary syndrome	5.47e-05	9.46e-05	CbGpPWpGaD
Celecoxib—PDPK1—Disease—SERPINE1—polycystic ovary syndrome	5.44e-05	9.41e-05	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—BCL2—polycystic ovary syndrome	5.42e-05	9.37e-05	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—AR—polycystic ovary syndrome	5.4e-05	9.34e-05	CbGpPWpGaD
Celecoxib—CA4—Metabolism—PPARG—polycystic ovary syndrome	5.39e-05	9.33e-05	CbGpPWpGaD
Celecoxib—CA9—Metabolism—MTHFR—polycystic ovary syndrome	5.37e-05	9.29e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—HSD3B1—polycystic ovary syndrome	5.32e-05	9.21e-05	CbGpPWpGaD
Celecoxib—CA4—Metabolism—POMC—polycystic ovary syndrome	5.32e-05	9.2e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—SRD5A1—polycystic ovary syndrome	5.31e-05	9.18e-05	CbGpPWpGaD
Celecoxib—CA4—Metabolism—INS—polycystic ovary syndrome	5.29e-05	9.15e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	5.26e-05	9.1e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	5.26e-05	9.1e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	5.18e-05	8.96e-05	CbGpPWpGaD
Celecoxib—CA2—Metabolism—PPARG—polycystic ovary syndrome	5.17e-05	8.94e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—YAP1—polycystic ovary syndrome	5.17e-05	8.94e-05	CbGpPWpGaD
Celecoxib—CA2—Metabolism—POMC—polycystic ovary syndrome	5.1e-05	8.82e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—GAB1—polycystic ovary syndrome	5.09e-05	8.82e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—FGF18—polycystic ovary syndrome	5.09e-05	8.81e-05	CbGpPWpGaD
Celecoxib—CA2—Metabolism—INS—polycystic ovary syndrome	5.07e-05	8.77e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—STAR—polycystic ovary syndrome	5.06e-05	8.76e-05	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	5.06e-05	8.76e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—RBP4—polycystic ovary syndrome	5.05e-05	8.74e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	5e-05	8.66e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	4.99e-05	8.63e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	4.99e-05	8.63e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—IRS2—polycystic ovary syndrome	4.96e-05	8.58e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—GNAS—polycystic ovary syndrome	4.91e-05	8.49e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—INSR—polycystic ovary syndrome	4.87e-05	8.43e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—LEP—polycystic ovary syndrome	4.85e-05	8.4e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—LHB—polycystic ovary syndrome	4.85e-05	8.4e-05	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—BCL2—polycystic ovary syndrome	4.83e-05	8.36e-05	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—IL6—polycystic ovary syndrome	4.81e-05	8.33e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IL18—polycystic ovary syndrome	4.76e-05	8.24e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—HSD3B2—polycystic ovary syndrome	4.74e-05	8.21e-05	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—NCOR1—polycystic ovary syndrome	4.72e-05	8.16e-05	CbGpPWpGaD
Celecoxib—MAPK14—Cellular responses to stress—IL6—polycystic ovary syndrome	4.67e-05	8.09e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—NRG1—polycystic ovary syndrome	4.65e-05	8.06e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—GAB1—polycystic ovary syndrome	4.65e-05	8.04e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—AKR1C3—polycystic ovary syndrome	4.63e-05	8.01e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PNPLA2—polycystic ovary syndrome	4.62e-05	8e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—AKR1C1—polycystic ovary syndrome	4.59e-05	7.95e-05	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—VEGFA—polycystic ovary syndrome	4.59e-05	7.94e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PNPLA2—polycystic ovary syndrome	4.58e-05	7.93e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	4.56e-05	7.9e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	4.56e-05	7.9e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—TNRC6B—polycystic ovary syndrome	4.56e-05	7.88e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—NAMPT—polycystic ovary syndrome	4.53e-05	7.83e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—HMMR—polycystic ovary syndrome	4.51e-05	7.81e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—PGR—polycystic ovary syndrome	4.51e-05	7.81e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—IL6—polycystic ovary syndrome	4.38e-05	7.59e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—SRD5A1—polycystic ovary syndrome	4.38e-05	7.58e-05	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—NR3C1—polycystic ovary syndrome	4.36e-05	7.55e-05	CbGpPWpGaD
Celecoxib—CA9—Metabolism—PPARG—polycystic ovary syndrome	4.36e-05	7.54e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—SRD5A1—polycystic ovary syndrome	4.34e-05	7.52e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—IRS1—polycystic ovary syndrome	4.33e-05	7.49e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—HSD3B1—polycystic ovary syndrome	4.31e-05	7.45e-05	CbGpPWpGaD
Celecoxib—CA9—Metabolism—POMC—polycystic ovary syndrome	4.3e-05	7.43e-05	CbGpPWpGaD
Celecoxib—CA9—Metabolism—INS—polycystic ovary syndrome	4.27e-05	7.39e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	4.26e-05	7.36e-05	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	4.25e-05	7.35e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	4.24e-05	7.34e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	4.23e-05	7.32e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—SULT2A1—polycystic ovary syndrome	4.23e-05	7.32e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—AKR1C3—polycystic ovary syndrome	4.22e-05	7.31e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—PLAT—polycystic ovary syndrome	4.19e-05	7.26e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—GHRL—polycystic ovary syndrome	4.19e-05	7.26e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—STAR—polycystic ovary syndrome	4.18e-05	7.23e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—POMC—polycystic ovary syndrome	4.17e-05	7.22e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—TNRC6B—polycystic ovary syndrome	4.16e-05	7.19e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—INS—polycystic ovary syndrome	4.15e-05	7.18e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—STAR—polycystic ovary syndrome	4.14e-05	7.17e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	4.1e-05	7.09e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—RRM2—polycystic ovary syndrome	4.09e-05	7.08e-05	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—VEGFA—polycystic ovary syndrome	4.09e-05	7.08e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	4.03e-05	6.98e-05	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—VEGFA—polycystic ovary syndrome	4.03e-05	6.97e-05	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—VEGFA—polycystic ovary syndrome	4.02e-05	6.95e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—IGF1—polycystic ovary syndrome	4.01e-05	6.94e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—AKT2—polycystic ovary syndrome	4.01e-05	6.94e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—ATF1—polycystic ovary syndrome	4e-05	6.92e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IRS2—polycystic ovary syndrome	3.99e-05	6.9e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CRP—polycystic ovary syndrome	3.99e-05	6.9e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—YAP1—polycystic ovary syndrome	3.95e-05	6.83e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—LHB—polycystic ovary syndrome	3.93e-05	6.79e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—TCF7L2—polycystic ovary syndrome	3.9e-05	6.75e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—HSD3B2—polycystic ovary syndrome	3.84e-05	6.64e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.81e-05	6.59e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—NAMPT—polycystic ovary syndrome	3.79e-05	6.56e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	3.77e-05	6.52e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—CYP11A1—polycystic ovary syndrome	3.74e-05	6.48e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	3.73e-05	6.45e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	3.72e-05	6.43e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—AKR1C1—polycystic ovary syndrome	3.72e-05	6.43e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—HMMR—polycystic ovary syndrome	3.69e-05	6.39e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—NGFR—polycystic ovary syndrome	3.69e-05	6.39e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—PRL—polycystic ovary syndrome	3.66e-05	6.33e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	3.61e-05	6.24e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	3.61e-05	6.24e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—TCF7L2—polycystic ovary syndrome	3.56e-05	6.16e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	3.55e-05	6.15e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—AKR1C3—polycystic ovary syndrome	3.54e-05	6.12e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—HSD3B1—polycystic ovary syndrome	3.52e-05	6.1e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—SLC2A4—polycystic ovary syndrome	3.5e-05	6.05e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	3.48e-05	6.03e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—CYP17A1—polycystic ovary syndrome	3.48e-05	6.02e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IRS1—polycystic ovary syndrome	3.48e-05	6.02e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—ADRB2—polycystic ovary syndrome	3.47e-05	6.01e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—SULT2A1—polycystic ovary syndrome	3.42e-05	5.92e-05	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—PPARG—polycystic ovary syndrome	3.38e-05	5.85e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—PRL—polycystic ovary syndrome	3.34e-05	5.78e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—RRM2—polycystic ovary syndrome	3.31e-05	5.73e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	3.3e-05	5.71e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	3.24e-05	5.61e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—AKT2—polycystic ovary syndrome	3.22e-05	5.58e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—GNAS—polycystic ovary syndrome	3.22e-05	5.57e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	3.21e-05	5.56e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—YAP1—polycystic ovary syndrome	3.19e-05	5.53e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—IGF1—polycystic ovary syndrome	3.18e-05	5.5e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—AKT2—polycystic ovary syndrome	3.18e-05	5.5e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	3.17e-05	5.48e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	3.14e-05	5.44e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	3.07e-05	5.31e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—NAMPT—polycystic ovary syndrome	3.07e-05	5.31e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—IL6—polycystic ovary syndrome	3.07e-05	5.31e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—NCOR1—polycystic ovary syndrome	3.07e-05	5.31e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	3.05e-05	5.28e-05	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—SERPINE1—polycystic ovary syndrome	3.04e-05	5.27e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	3.04e-05	5.26e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CYP11A1—polycystic ovary syndrome	3.03e-05	5.24e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	3.02e-05	5.23e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—SERPINE1—polycystic ovary syndrome	3.02e-05	5.22e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—TH—polycystic ovary syndrome	3.01e-05	5.21e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—NRG1—polycystic ovary syndrome	3.01e-05	5.21e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	3.01e-05	5.2e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—SLC2A4—polycystic ovary syndrome	2.93e-05	5.07e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	2.87e-05	4.96e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—AKR1C3—polycystic ovary syndrome	2.86e-05	4.95e-05	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—IL6—polycystic ovary syndrome	2.83e-05	4.9e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	2.82e-05	4.89e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CYP17A1—polycystic ovary syndrome	2.82e-05	4.87e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—BCL2—polycystic ovary syndrome	2.81e-05	4.87e-05	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—IL6—polycystic ovary syndrome	2.8e-05	4.85e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	2.8e-05	4.84e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—NCOR1—polycystic ovary syndrome	2.8e-05	4.84e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—CYP19A1—polycystic ovary syndrome	2.76e-05	4.77e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—NRG1—polycystic ovary syndrome	2.75e-05	4.75e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	2.73e-05	4.73e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	2.73e-05	4.73e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	2.71e-05	4.69e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	2.64e-05	4.56e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.62e-05	4.53e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	2.61e-05	4.52e-05	CbGpPWpGaD
Celecoxib—PDPK1—Disease—IL6—polycystic ovary syndrome	2.59e-05	4.48e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IRS2—polycystic ovary syndrome	2.58e-05	4.46e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	2.53e-05	4.38e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—LEP—polycystic ovary syndrome	2.52e-05	4.37e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	2.51e-05	4.35e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	2.5e-05	4.33e-05	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—IL6—polycystic ovary syndrome	2.5e-05	4.33e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	2.5e-05	4.32e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	2.48e-05	4.29e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—MTHFR—polycystic ovary syndrome	2.47e-05	4.28e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	2.46e-05	4.26e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—GNAS—polycystic ovary syndrome	2.46e-05	4.26e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—TH—polycystic ovary syndrome	2.44e-05	4.22e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	2.44e-05	4.22e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—SLC2A4—polycystic ovary syndrome	2.37e-05	4.1e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	2.36e-05	4.09e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—IRS2—polycystic ovary syndrome	2.35e-05	4.07e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—NCOR1—polycystic ovary syndrome	2.34e-05	4.05e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	2.34e-05	4.05e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	2.33e-05	4.02e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	2.32e-05	4.02e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	2.31e-05	3.99e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IRS1—polycystic ovary syndrome	2.25e-05	3.89e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CYP19A1—polycystic ovary syndrome	2.23e-05	3.86e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—CYP1A1—polycystic ovary syndrome	2.22e-05	3.84e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—POMC—polycystic ovary syndrome	2.17e-05	3.75e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—INS—polycystic ovary syndrome	2.16e-05	3.73e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	2.12e-05	3.67e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IGF1—polycystic ovary syndrome	2.08e-05	3.61e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—AKT2—polycystic ovary syndrome	2.08e-05	3.6e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—VEGFA—polycystic ovary syndrome	2.08e-05	3.59e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	2.07e-05	3.58e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—MTHFR—polycystic ovary syndrome	2.07e-05	3.58e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—IRS1—polycystic ovary syndrome	2.05e-05	3.55e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—TH—polycystic ovary syndrome	2.01e-05	3.48e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	2.01e-05	3.47e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—TH—polycystic ovary syndrome	1.99e-05	3.45e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—GNAS—polycystic ovary syndrome	1.99e-05	3.44e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.98e-05	3.43e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—INS—polycystic ovary syndrome	1.97e-05	3.4e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	1.96e-05	3.39e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	1.94e-05	3.36e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—AKT2—polycystic ovary syndrome	1.9e-05	3.29e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—NCOR1—polycystic ovary syndrome	1.9e-05	3.28e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	1.85e-05	3.19e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	1.84e-05	3.18e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	1.82e-05	3.16e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—IL6—polycystic ovary syndrome	1.81e-05	3.14e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—SERPINE1—polycystic ovary syndrome	1.81e-05	3.13e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CYP1A1—polycystic ovary syndrome	1.8e-05	3.11e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	1.79e-05	3.09e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	1.72e-05	2.98e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—PPARG—polycystic ovary syndrome	1.68e-05	2.91e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—MTHFR—polycystic ovary syndrome	1.67e-05	2.9e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	1.66e-05	2.87e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—POMC—polycystic ovary syndrome	1.66e-05	2.87e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—INS—polycystic ovary syndrome	1.65e-05	2.85e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	1.64e-05	2.84e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	1.64e-05	2.83e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	1.63e-05	2.82e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	1.56e-05	2.71e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	1.55e-05	2.68e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	1.54e-05	2.67e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	1.52e-05	2.63e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	1.48e-05	2.57e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	1.47e-05	2.54e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IL6—polycystic ovary syndrome	1.46e-05	2.52e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	1.38e-05	2.39e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	1.37e-05	2.37e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.36e-05	2.36e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PPARG—polycystic ovary syndrome	1.36e-05	2.35e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—POMC—polycystic ovary syndrome	1.34e-05	2.32e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—INS—polycystic ovary syndrome	1.33e-05	2.31e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—TH—polycystic ovary syndrome	1.32e-05	2.28e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	1.28e-05	2.21e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	1.2e-05	2.08e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	1.12e-05	1.94e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	1.11e-05	1.92e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	1.11e-05	1.91e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—INS—polycystic ovary syndrome	1.1e-05	1.9e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	1.1e-05	1.9e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—INS—polycystic ovary syndrome	1.09e-05	1.89e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	1.07e-05	1.86e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	1.02e-05	1.77e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	9.7e-06	1.68e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IL6—polycystic ovary syndrome	9.42e-06	1.63e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	9.04e-06	1.56e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—IL6—polycystic ovary syndrome	8.59e-06	1.49e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	7.33e-06	1.27e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	7.23e-06	1.25e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—INS—polycystic ovary syndrome	7.19e-06	1.24e-05	CbGpPWpGaD
